BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 30467411)

  • 1. Prospective multicenter real-world RAS mutation comparison between OncoBEAM-based liquid biopsy and tissue analysis in metastatic colorectal cancer.
    García-Foncillas J; Tabernero J; Élez E; Aranda E; Benavides M; Camps C; Jantus-Lewintre E; López R; Muinelo-Romay L; Montagut C; Antón A; López G; Díaz-Rubio E; Rojo F; Vivancos A
    Br J Cancer; 2018 Dec; 119(12):1464-1470. PubMed ID: 30467411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood-based detection of RAS mutations to guide anti-EGFR therapy in colorectal cancer patients: concordance of results from circulating tumor DNA and tissue-based RAS testing.
    Schmiegel W; Scott RJ; Dooley S; Lewis W; Meldrum CJ; Pockney P; Draganic B; Smith S; Hewitt C; Philimore H; Lucas A; Shi E; Namdarian K; Chan T; Acosta D; Ping-Chang S; Tannapfel A; Reinacher-Schick A; Uhl W; Teschendorf C; Wolters H; Stern J; Viebahn R; Friess H; Janssen KP; Nitsche U; Slotta-Huspenina J; Pohl M; Vangala D; Baraniskin A; Dockhorn-Dworniczak B; Hegewisch-Becker S; Ronga P; Edelstein DL; Jones FS; Hahn S; Fox SB
    Mol Oncol; 2017 Feb; 11(2):208-219. PubMed ID: 28106345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the Clinical Sensitivity of the Idylla Platform and the OncoBEAM RAS CRC Assay for KRAS Mutation Detection in Liquid Biopsy Samples.
    Vivancos A; Aranda E; Benavides M; Élez E; Gómez-España MA; Toledano M; Alvarez M; Parrado MRC; García-Barberán V; Diaz-Rubio E
    Sci Rep; 2019 Jun; 9(1):8976. PubMed ID: 31222012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multicentre, prospective study of plasma circulating tumour DNA test for detecting RAS mutation in patients with metastatic colorectal cancer.
    Bando H; Kagawa Y; Kato T; Akagi K; Denda T; Nishina T; Komatsu Y; Oki E; Kudo T; Kumamoto H; Yamanaka T; Yoshino T
    Br J Cancer; 2019 May; 120(10):982-986. PubMed ID: 31015557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma ctDNA RAS mutation analysis for the diagnosis and treatment monitoring of metastatic colorectal cancer patients.
    Vidal J; Muinelo L; Dalmases A; Jones F; Edelstein D; Iglesias M; Orrillo M; Abalo A; Rodríguez C; Brozos E; Vidal Y; Candamio S; Vázquez F; Ruiz J; Guix M; Visa L; Sikri V; Albanell J; Bellosillo B; López R; Montagut C
    Ann Oncol; 2017 Jun; 28(6):1325-1332. PubMed ID: 28419195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concordance of blood- and tumor-based detection of RAS mutations to guide anti-EGFR therapy in metastatic colorectal cancer.
    Grasselli J; Elez E; Caratù G; Matito J; Santos C; Macarulla T; Vidal J; Garcia M; Viéitez JM; Paéz D; Falcó E; Lopez Lopez C; Aranda E; Jones F; Sikri V; Nuciforo P; Fasani R; Tabernero J; Montagut C; Azuara D; Dienstmann R; Salazar R; Vivancos A
    Ann Oncol; 2017 Jun; 28(6):1294-1301. PubMed ID: 28368441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RAS testing of liquid biopsy correlates with the outcome of metastatic colorectal cancer patients treated with first-line FOLFIRI plus cetuximab in the CAPRI-GOIM trial.
    Normanno N; Esposito Abate R; Lambiase M; Forgione L; Cardone C; Iannaccone A; Sacco A; Rachiglio AM; Martinelli E; Rizzi D; Pisconti S; Biglietto M; Bordonaro R; Troiani T; Latiano TP; Giuliani F; Leo S; Rinaldi A; Maiello E; Ciardiello F;
    Ann Oncol; 2018 Jan; 29(1):112-118. PubMed ID: 28950295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KRAS and NRAS mutational analysis in plasma ctDNA from patients with metastatic colorectal cancer by real-time PCR and digital PCR.
    Pinheiro M; Peixoto A; Rocha P; Veiga I; Pinto C; Santos C; Pinto P; Guerra J; Escudeiro C; Barbosa A; Silva J; Teixeira MR
    Int J Colorectal Dis; 2022 Apr; 37(4):895-905. PubMed ID: 35303157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood-based
    Germetaki T; Nicholls C; Adams RA; Braun M; Rogan J; Moghadam S; Lenfert E; Lukas A; Edelstein DL; Jones FS; Saunders MP
    Future Oncol; 2020 Oct; 16(28):2177-2189. PubMed ID: 32716216
    [No Abstract]   [Full Text] [Related]  

  • 10. Incorporating BEAMing technology as a liquid biopsy into clinical practice for the management of colorectal cancer patients: an expert taskforce review.
    García-Foncillas J; Alba E; Aranda E; Díaz-Rubio E; López-López R; Tabernero J; Vivancos A
    Ann Oncol; 2017 Dec; 28(12):2943-2949. PubMed ID: 28945877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamic molecular analysis and clinical correlates of tumor evolution within a phase II trial of panitumumab-based therapy in metastatic colorectal cancer.
    Siena S; Sartore-Bianchi A; Garcia-Carbonero R; Karthaus M; Smith D; Tabernero J; Van Cutsem E; Guan X; Boedigheimer M; Ang A; Twomey B; Bach BA; Jung AS; Bardelli A
    Ann Oncol; 2018 Jan; 29(1):119-126. PubMed ID: 28945848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of colorectal cancer-related mutations by liquid biopsy: Utility of circulating cell-free DNA and circulating tumor cells.
    Takeda K; Yamada T; Takahashi G; Iwai T; Ueda K; Kuriyama S; Koizumi M; Matsuda A; Shinji S; Ohta R; Yokoyama Y; Hotta M; Hara K; Yoshida H
    Cancer Sci; 2019 Nov; 110(11):3497-3509. PubMed ID: 31465598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical validation of prospective liquid biopsy monitoring in patients with wild-type RAS metastatic colorectal cancer treated with FOLFIRI-cetuximab.
    Toledo RA; Cubillo A; Vega E; Garralda E; Alvarez R; de la Varga LU; Pascual JR; Sánchez G; Sarno F; Prieto SH; Perea S; Lopéz-Casas PP; López-Ríos F; Hidalgo M
    Oncotarget; 2017 May; 8(21):35289-35300. PubMed ID: 27852040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined Analysis of Concordance between Liquid and Tumor Tissue Biopsies for
    Kagawa Y; Elez E; García-Foncillas J; Bando H; Taniguchi H; Vivancos A; Akagi K; García A; Denda T; Ros J; Nishina T; Baraibar I; Komatsu Y; Ciardiello D; Oki E; Kudo T; Kato T; Yamanaka T; Tabernero J; Yoshino T
    Clin Cancer Res; 2021 May; 27(9):2515-2522. PubMed ID: 33602686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emergence of RAS mutations in patients with metastatic colorectal cancer receiving cetuximab-based treatment: a study protocol.
    Chen SH; Tsai HL; Jiang JK; Sung YC; Huang CW; Yeh YM; Chen LT; Wang JY
    BMC Cancer; 2019 Jun; 19(1):640. PubMed ID: 31253124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Correlation analysis between abundance of K-ras mutation in plasma free DNA and its correlation with clinical outcome and prognosis in patients with metastatic colorectal cancer].
    Bai YQ; Liu XJ; Wang Y; Ge FJ; Zhao CH; Fu YL; Lin L; Xu JM
    Zhonghua Zhong Liu Za Zhi; 2013 Sep; 35(9):666-71. PubMed ID: 24332053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RAS/BRAF Circulating Tumor DNA Mutations as a Predictor of Response to First-Line Chemotherapy in Metastatic Colorectal Cancer Patients.
    Yao J; Zang W; Ge Y; Weygant N; Yu P; Li L; Rao G; Jiang Z; Yan R; He L; Yu Y; Jin M; Cheng G; An G
    Can J Gastroenterol Hepatol; 2018; 2018():4248971. PubMed ID: 29707525
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Lastraioli E; Antonuzzo L; Fantechi B; Di Cerbo L; Di Costanzo A; Lavacchi D; Armenio M; Arcangeli A; Castiglione F; Messerini L; Di Costanzo F
    Oncol Lett; 2021 Jan; 21(1):15. PubMed ID: 33240421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma Dynamics of RAS/RAF Mutations in Patients With Metastatic Colorectal Cancer Receiving Chemotherapy and Anti-EGFR Treatment.
    Thomsen CB; Andersen RF; Lindebjerg J; Hansen TF; Jensen LH; Jakobsen A
    Clin Colorectal Cancer; 2019 Mar; 18(1):28-33.e3. PubMed ID: 30459076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective capture of plasma cell-free tumor DNA on magnetic beads: a sensitive and versatile tool for liquid biopsy.
    Kerachian MA; Azghandi M; Javadmanesh A; Ghaffarzadegan K; Mozaffari-Jovin S
    Cell Oncol (Dordr); 2020 Oct; 43(5):949-956. PubMed ID: 32495293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.